At the International Innovation Forum of the 9th All Blossom Conference,the Hangzhou Venture Capital Association, and Bank of Hangzhou jointly released the 2025 Hangzhou Unicorn and Quasi-unicorn Enterprise List. Viablife, recognized for its strong innovation capabilities, high growth potential, and significant market presence, has once again been named a Hangzhou Quasi-unicorn Enterprise—marking its third consecutive year on the list!
Significance of Unicorn Enterprises
Unicorn enterprises serve as key indicators of new economic development. Typically, they are young companies valued at over USD 1 billion, distinguished by their proprietary technologies, strong competitive advantages, and significant market potential. As micro-carriers of emerging productive forces, unicorn enterprises play a vital role in driving innovation and stimulating growth across diverse sectors of the economy.
Viablife's Achievements and Future Prospects
As of April 2025, Hangzhou is home to 44 unicorn enterprises—each valued at no less than USD 1 billion—and 397 quasi-unicorn enterprises with valuations exceeding USD 100 million. Viablife has not only sustained its status as a quasi-unicorn enterprise but has also been named one of the “21 Little Giants” among quasi-unicorns in the life and health sector for 2025, highlighting its continued leadership and innovation in the field.
Viablife' s continued recognition as a quasi-unicorn enterprise reflects its unwavering commitment to innovation and excellence. In the highly competitive and innovation-driven life and health sector, Viablife has distinguished itself through its proprietary technologies and strategic foresight. Its consistent ability to deliver value and push technological boundaries has earned the trust and recognition of investors, partners, and the broader business community.
Looking ahead, Viablife is well-positioned to sustain its momentum of growth and innovation. Backed by Hangzhou’s dynamic entrepreneurial ecosystem and recognition from leading institutions, the company is poised to seize new opportunities, expand its global footprint, and play a pivotal role in advancing the life and health industry worldwide.